肺移植后肺癌:早期发现与根治性手术驱动长期生存
这项多中心回顾性队列研究纳入2000至2023年间肺移植或心肺联合移植后诊断原发性肺癌的连续患者,分析其临床特征、分期、治疗方式与结局。7313例受者中143例(2%)发生肺癌,中位间隔5.3年。根治性手术(避免全肺切除)和放疗使早期移植后肺癌获得良好长期生存,早期与晚期生存差异显著,强调对所有受者尤其是单肺移植后常规低剂量CT筛查的重要性。
要点
- 肺移植后肺癌发生率2%,中位间隔5.3年,单肺移植者84%发生于自体肺。
- 根治性手术以开胸为主(79%),R0切除率93%,肺叶切除后90天死亡率5%,全肺切除33%。
- I期患者中位总生存83个月,II、III、IV期分别为16、10、6个月,强调早期筛查。
核心结论
- 避免全肺切除的根治性手术切除和放疗可使早期移植后肺癌获得良好长期生存。
- 早期与晚期移植后肺癌生存差异显著,强调对所有受者常规低剂量CT筛查的重要性,尤其是单肺移植后。
研究设计与样本
- 多中心回顾性观察性队列研究,纳入2000至2023年间诊断的肺移植或心肺联合移植后原发性肺癌连续患者。
- 共7313例受者,143例(2%)发生肺癌,并与无移植后肺癌的对照受者比较。
- 采用Kaplan-Meier法评估生存。
主要发现
- 60例(42%)接受根治性意向手术,其中79%经开胸完成,57例中53例(93%)实现R0切除。
- 肺叶切除后90天死亡率为5%,全肺切除后为33%。
- 31例(21%)接受根治性意向放疗,其中3例发生3级或4级放射性肺毒性。
- I、II、III、IV期患者中位总生存分别为83、16、10、6个月。
临床怎么用
- 对肺移植受者,尤其是单肺移植后,应常规进行低剂量CT筛查以早期发现肺癌。
- 早期移植后肺癌应优先考虑根治性手术切除,并尽量避免全肺切除以降低90天死亡率。
- 根治性放疗可作为早期移植后肺癌的治疗选择,但需警惕3级或4级放射性肺毒性。
局限性
- 回顾性观察性设计可能存在选择偏倚和混杂因素。
- 原文未报告多变量校正分析或倾向性评分匹配等控制混杂的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer (LC) after lung transplantation (LTx) is a rare but severe complication whose treatment and outcomes remain unclear. METHODS: This multicenter retrospective observational cohort study included consecutive patients diagnosed between 2000 and 2023 with primary LC after LTx or heart-LTx. Patient characteristics, cancer stage, treatment modalities, and outcomes were analyzed. Survival was assessed using Kaplan-Meier methods. We compared the cohort to control recipients without post-transplantation LC. RESULTS: Of 7,313 recipients, 143 (2%) developed LC, after a median interval of 5.3 years. Fifty-five cancers (37%) were stage I disease and 53 (35%) were metastatic disease. In 60 (42%) patients, curative-intent surgery, predominantly via a thoracotomy (79%), was performed and achieved R0 resection in 53 of 57 (93%) patients. Day-90 mortality was 5% after lobectomy and 33% after pneumonectomy. Of the 31 (21%) patients given curative-intent radiotherapy, 3 developed radiation-induced grade 3 or 4 lung toxicity. Median overall survival in patients with stage I, II, III, and IV disease was 83, 16, 10, and 6 months, respectively. Compared to controls, patients with LC were older at transplantation, had greater donor and recipient smoking exposure, and more often received single LTx (43% vs 16%). Of the 62 single-LTx recipients, 52 (84%) had LC in the native lung. CONCLUSIONS: Curative-intent surgical resection, when avoiding pneumonectomy, and radiotherapy yield good long-term survival in early-stage post-transplantation LC. The dramatic survival differences between early and advanced stages emphasize the critical importance of routine low-dose computed tomography screening in all recipients, notably after single LTx.
引用
- Saing S, El Husseini K, Picard C, et al. Lung cancer after lung transplantation: Early detection and curative surgery drive long-term survival. J Heart Lung Transplant. 2025. PMID: 41412358. doi:10.1016/j.healun.2025.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。